Seller record · Telehealth service

Walgreens Weight Management

Fails 2 of 8 criteria. S3, pharmacy identification: The program page does not name the pharmacy that fills a weight management prescription. It names the chain's own pharmacy only for a separate Medicare program, and the virtual care page says only that a prescription can be filled in store or delivered. 1 more criterion also fails; see the table below.

At a glance

Walgreens Weight ManagementTelehealth service

6/8criteria passed
Price
Visits $49; Wegovy pill and Foundayo from $149 a month with a manufacturer offer
Sells
Wegovy pill, Wegovy injection, Zepbound KwikPen and vials, and 3 more
FDA letters
1 on file
Visit Walgreens Weight ManagementSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

The weight management program of a national pharmacy chain's virtual care service, in which a doctor or nurse practitioner from its affiliated medical practices meets the patient by video and may prescribe a brand GLP-1 drug: Wegovy, Zepbound, Foundayo or Saxenda. Visits are paid one at a time with no subscription, and the medication is priced separately through the manufacturers' self-pay offers.

Operating entity Walgreen Co.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSWalgreens Weight Management's weight loss page; Walgreens Weight Management's terms of use page
S2Prescription gatingPASSWalgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page
S3Pharmacy identificationFAILWalgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page
S4Compounding disclosurePASSWalgreens Weight Management's weight loss page
S5Analytical documentationFAILWalgreens Weight Management's weight loss page
S6Business addressPASSWalgreens Weight Management's terms of use page
S7Price disclosurePASSWalgreens Weight Management's weight loss page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA doctor or nurse practitioner reviews the medical history in a video visit and prescribes only if appropriate, and the page says a prescription depends on a medical evaluation and is not guaranteed. The terms say the Walgreens-branded medical practices, among them Walgreens Health Medical Group, P.A., are owned and operated by licensed physicians.Source: Walgreens Weight Management's weight loss page; Walgreens Weight Management's terms of use page.
S2PASSThe answers on the program page say the buyer first completes a short online questionnaire about health history and eligibility, and only if qualified starts a video visit with a provider who decides whether to prescribe. The visit fee is paid for the visit, and no medication is sold before the provider's evaluation.Source: Walgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page.
S3FAILThe program page does not name the pharmacy that fills a weight management prescription. It names the chain's own pharmacy only for a separate Medicare program, and the virtual care page says only that a prescription can be filled in store or delivered.Source: Walgreens Weight Management's weight loss page; Walgreens Weight Management's virtual healthcare page.
S4PASSThe seller offers no compounded drug through this program: the program page lists only Wegovy, Zepbound, Foundayo and Saxenda and describes each as FDA-approved for weight loss.Source: Walgreens Weight Management's weight loss page.
S5FAILNo certificate, lot number or purity document appears on the program page, the virtual care page or the terms.Source: Walgreens Weight Management's weight loss page.
S6PASSWalgreen Co., whose terms give 104 Wilmot Road, MS 1431, Deerfield, IL 60015 as the address of its Litigation and Regulatory Law Department, with a separate notice address in care of Illinois Corporation Service Company in Springfield, Illinois. The terms name Illinois law.Source: Walgreens Weight Management's terms of use page.
S7PASSVisits cost $49 each with no subscription, and the medication is billed separately. Through manufacturer self-pay offers the Wegovy pill and Foundayo start at $149 a month with later doses from $199 to $299, Zepbound pens start at $299 a month with later doses from $399 to $449, and Wegovy injections cost $199 a month for the first two fills as an introductory offer, then up to $349 a month.Source: Walgreens Weight Management's weight loss page.
S8PASSFDA warning letter 663404, September 2023, names the parent company Walgreens Boots Alliance, Inc. and the seller's own website, and alleges that homeopathic eye drops sold under the Walgreens name are unapproved new drugs. A second September 2023 letter names Walgreen Company over the drug listing of a Walgreens toothpaste. Neither concerns weight loss medication. No FDA action has halted the business, and the company continues to operate.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Wegovy pill, Wegovy injection, Zepbound KwikPen and vials, Foundayo, Saxenda, weight management video visit.

Enforcement documents on file: 1 warning letter

FDA warning letter 663404, issued September 2023, to Walgreens Boots Alliance, Inc.Homeopathic eye drops sold under the Walgreens name on Walgreens Weight Management's website are unapproved new drugs, and are adulterated because a contract manufacturer made them outside current good manufacturing practice.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Walgreens Weight Management

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.